FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
The FDA approved the first generic version of Climara Pro, a once-weekly transdermal hormone therapy patch for women.
The FDA approved the first generic version of Climara Pro, a once-weekly transdermal hormone therapy patch for women.